Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Crinetics Pharmaceuticals Inc buy Evercore ISI

Start price
€25.00
11.09.23 / 50%
Target price
€44.61
11.09.24
Performance (%)
84.80%
End price
€46.20
12.09.24
Summary
This prediction ended on 12.09.24 with a price of €46.20. The BUY prediction by Evercore_ISI for Crinetics Pharmaceuticals Inc saw massive gains of 84.80%. Evercore_ISI has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Crinetics Pharmaceuticals Inc 7.930% 7.930% 88.462%
iShares Core DAX® -1.471% 1.895% 25.178%
iShares Nasdaq 100 -0.486% 4.395% 29.415%
iShares Nikkei 225® -2.115% 2.450% 20.561%
iShares S&P 500 0.394% 3.118% 29.456%

Comments by Evercore_ISI for this prediction

In the thread Crinetics Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) 84.80%
Target price 44.606
Change
Ends at 11.09.24

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Evercore ISI from $41.00 to $48.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat

In the thread Trading Crinetics Pharmaceuticals Inc
Prediction Buy
Perf. (%) 84.80%
Target price 44.606
Change
Ends at 11.09.24

Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten